Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates


Growth differentiation factor 15 (GDF15), a distant member of the transforming growth factor (TGF)-β family, is a secreted protein that circulates as a 25-kDa dimer. In humans, elevated GDF15 correlates with weight loss, and the administration of GDF15 to mice with obesity reduces body weight, at least in part, by decreasing food intake. The mechanisms through which GDF15 reduces body weight remain poorly understood, because the cognate receptor for GDF15 is unknown. Here we show that recombinant GDF15 induces weight loss in mice fed a high-fat diet and in nonhuman primates with spontaneous obesity. Furthermore, we find that GDF15 binds with high affinity to GDNF family receptor α–like (GFRAL), a distant relative of receptors for a distinct class of the TGF-β superfamily ligands. Gfral is expressed in neurons of the area postrema and nucleus of the solitary tract in mice and humans, and genetic deletion of the receptor abrogates the ability of GDF15 to decrease food intake and body weight in mice. In addition, diet-induced obesity and insulin resistance are exacerbated in GFRAL-deficient mice, suggesting a homeostatic role for this receptor in metabolism. Finally, we demonstrate that GDF15-induced cell signaling requires the interaction of GFRAL with the coreceptor RET. Our data identify GFRAL as a new regulator of body weight and as the bona fide receptor mediating the metabolic effects of GDF15, enabling a more comprehensive assessment of GDF15 as a potential pharmacotherapy for the treatment of obesity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: GDF15 drives body-weight loss through food-intake reduction in mice and nonhuman primates.
Figure 2: GDF15 binds to GFRAL.
Figure 3: GFRAL attenuates diet-induced obesity and insulin resistance.
Figure 4: GFRAL is necessary for GDF15-mediated food intake reduction and weight loss.
Figure 5: GDF15–GFRAL interaction is necessary but not sufficient for the effects of GDF15.
Figure 6: GDF15 induces GFRAL interaction with coreceptor RET to enable downstream signaling.

Similar content being viewed by others

Accession codes


Protein Data Bank


  1. Ng, M. et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384, 766–781 (2014).

    Article  Google Scholar 

  2. Heymsfield, S.B. & Wadden, T.A. Mechanisms, pathophysiology, and management of Obesity. N. Engl. J. Med. 376, 254–266 (2017).

    Article  CAS  Google Scholar 

  3. Khera, R. et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. J. Am. Med. Assoc. 315, 2424–2434 (2016).

    Article  CAS  Google Scholar 

  4. Johnen, H. et al. Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Nat. Med. 13, 1333–1340 (2007).

    Article  CAS  Google Scholar 

  5. Macia, L. et al. Macrophage inhibitory cytokine 1 (MIC-1/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets. PLoS One 7, e34868 (2012).

    Article  CAS  Google Scholar 

  6. Chrysovergis, K. et al. NAG-1/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism. Int. J. Obes. 38, 1555–1564 (2014).

    Article  CAS  Google Scholar 

  7. Wang, X. et al. hNAG-1 increases lifespan by regulating energy metabolism and insulin/IGF-1/mTOR signaling. Aging 6, 690–704 (2014).

    Article  CAS  Google Scholar 

  8. Morrow, R.M. et al. Mitochondrial energy deficiency leads to hyperproliferation of skeletal muscle mitochondria and enhanced insulin sensitivity. Proc. Natl. Acad. Sci. USA 114, 2705–2710 (2017).

    Article  CAS  Google Scholar 

  9. Chung, H.K. et al. Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis. J. Cell Biol. 216, 149–165 (2017).

    Article  CAS  Google Scholar 

  10. Tsai, V.W. et al. TGF-b superfamily cytokine MIC-1/GDF15 is a physiological appetite and body weight regulator. PLoS One 8, e55174 (2013).

    Article  CAS  Google Scholar 

  11. Tsai, V.W. et al. The anorectic actions of the TGFβ cytokine MIC-1/GDF15 require an intact brainstem area postrema and nucleus of the solitary tract. PLoS One 9, e100370 (2014).

    Article  Google Scholar 

  12. Brown, D.A. et al. Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet 359, 2159–2163 (2002).

    Article  CAS  Google Scholar 

  13. Kempf, T. et al. Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction. Eur. Heart J. 28, 2858–2865 (2007).

    Article  CAS  Google Scholar 

  14. Kempf, T. et al. Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial. Eur. J. Endocrinol. 167, 671–678 (2012).

    Article  CAS  Google Scholar 

  15. Tsai, V.W. et al. Serum levels of human MIC-1/GDF15 vary in a diurnal pattern, do not display a profile suggestive of a satiety factor and are related to BMI. PLoS One 10, e0133362 (2015).

    Article  Google Scholar 

  16. Tsai, V.W. et al. Anorexia/cachexia of chronic diseases: a role for the TGF-β family cytokine MIC-1/GDF15. J. Cachexia Sarcopenia Muscle 3, 239–243 (2012).

    Article  Google Scholar 

  17. Artz, A., Butz, S. & Vestweber, D. GDF-15 inhibits integrin activation and mouse neutrophil recruitment through the ALK-5/TGF-βRII heterodimer. Blood 128, 529–541 (2016).

    Article  CAS  Google Scholar 

  18. Wang, C.Y., Huang, A.Q., Zhou, M.H. & Mei, Y.A. GDF15 regulates Kv2.1-mediated outward K+ current through the Akt/mTOR signalling pathway in rat cerebellar granule cells. Biochem. J. 460, 35–47 (2014).

    Article  CAS  Google Scholar 

  19. de Jager, S.C. et al. Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis. J. Exp. Med. 208, 217–225 (2011).

    Article  CAS  Google Scholar 

  20. Li, Z. et al. Identification, expression and functional characterization of the GRAL gene. J. Neurochem. 95, 361–376 (2005).

    Article  CAS  Google Scholar 

  21. Hätinen, T., Holm, L. & Airaksinen, M.S. Loss of neurturin in frog--comparative genomics study of GDNF family ligand-receptor pairs. Mol. Cell. Neurosci. 34, 155–167 (2007).

    Article  Google Scholar 

  22. Vieira, P., Thomas-Crusells, J. & Vieira, A. Internalization of glial cell-derived neurotrophic factor receptor GFR alpha 1 in the absence of the ret tyrosine kinase coreceptor. Cell. Mol. Neurobiol. 23, 43–55 (2003).

    Article  CAS  Google Scholar 

  23. Hayes, M.R., Skibicka, K.P. & Grill, H.J. Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation. Endocrinology 149, 4059–4068 (2008).

    Article  CAS  Google Scholar 

  24. Akhurst, R.J. & Hata, A. Targeting the TGFβ signalling pathway in disease. Nat. Rev. Drug Discov. 11, 790–811 (2012).

    Article  CAS  Google Scholar 

  25. Allendorph, G.P., Isaacs, M.J., Kawakami, Y., Izpisua Belmonte, J.C. & Choe, S. BMP-3 and BMP-6 structures illuminate the nature of binding specificity with receptors. Biochemistry 46, 12238–12247 (2007).

    Article  CAS  Google Scholar 

  26. Allendorph, G.P., Vale, W.W. & Choe, S. Structure of the ternary signaling complex of a TGF-beta superfamily member. Proc. Natl. Acad. Sci. USA 103, 7643–7648 (2006).

    Article  CAS  Google Scholar 

  27. Greenwald, J. et al. The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol. Cell 11, 605–617 (2003).

    Article  CAS  Google Scholar 

  28. Parkash, V. & Goldman, A. Comparison of GFL-GFRalpha complexes: further evidence relating GFL bend angle to RET signalling. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 65, 551–558 (2009).

    Article  CAS  Google Scholar 

  29. Goodman, K.M. et al. RET recognition of GDNF-GFRα1 ligand by a composite binding site promotes membrane-proximal self-association. Cell Rep. 8, 1894–1904 (2014).

    Article  CAS  Google Scholar 

  30. Airaksinen, M.S. & Saarma, M. The GDNF family: signalling, biological functions and therapeutic value. Nat. Rev. Neurosci. 3, 383–394 (2002).

    Article  CAS  Google Scholar 

  31. Alao, J.P., Michlikova, S., Dinér, P., Grøtli, M. & Sunnerhagen, P. Selective inhibition of RET mediated cell proliferation in vitro by the kinase inhibitor SPP86. BMC Cancer 14, 853 (2014).

    Article  Google Scholar 

  32. Ding, Q. et al. Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes. Endocrinology 150, 1688–1696 (2009).

    Article  CAS  Google Scholar 

  33. Verdeguer, F. et al. Brown adipose YY1 deficiency activates expression of secreted proteins linked to energy expenditure and prevents diet-induced obesity. Mol. Cell. Biol. 36, 184–196 (2015).

    PubMed  PubMed Central  Google Scholar 

  34. Hasebe, T. et al. Bone morphogenetic protein-binding endothelial regulator of liver sinusoidal endothelial cells induces iron overload in a fatty liver mouse model. J. Gastroenterol. 52, 341–351 (2017).

    Article  CAS  Google Scholar 

  35. Quartu, M. et al. Tissue distribution of Ret, GFRalpha-1, GFRalpha-2 and GFRalpha-3 receptors in the human brainstem at fetal, neonatal and adult age. Brain Res. 1173, 36–52 (2007).

    Article  CAS  Google Scholar 

  36. Bauskin, A.R. et al. The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-beta superfamily member, acts as a quality control determinant for correctly folded MIC-1. EMBO J. 19, 2212–2220 (2000).

    Article  CAS  Google Scholar 

  37. Merchant, A.M. et al. An efficient route to human bispecific IgG. Nat. Biotechnol. 16, 677–681 (1998).

    Article  CAS  Google Scholar 

  38. Turner, L. et al. Severe malaria is associated with parasite binding to endothelial protein C receptor. Nature 498, 502–505 (2013).

    Article  CAS  Google Scholar 

Download references


We thank the following people for technical assistance in carrying out this work: B. Geist, Y. Wang, L. Lu, M. Husovsky (all at Janssen Research and Development). We thank E. Chi, S. Fenton, V. Stojanovic-Susulic, R. Swanson, J. Leonard and M. Erion (Janssen Research and Development) for support and insightful discussions. S.C.B., T.D.C.-M., C.R.C., and V.J.S. were employees of Kelly Outsourcing & Consulting Group. The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the US National Institutes of Health, and by the NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS.

Author information

Authors and Affiliations



J.L.F., S.N., C.H., C.-N.C., M.J.H. and X.L.-S. contributed to protein design, generation and characterization. A.A.A. contributed to data interpretation and performed homology modeling. T.Q.D. designed and executed SPR experiments. J.A.C., S.C.B., V.J.S., X.L-S., C.-N.C. designed and executed in vitro studies. S.E.M. and S.M.R. designed all animal experiments which were executed by S.E.M., T.D.C.-M., and C.R.C. S.E.M., X.L.-S., C.-N.C., J.A.C. and S.M.R. contributed to all study design, data interpretation and wrote the manuscript.

Corresponding author

Correspondence to Shamina M Rangwala.

Ethics declarations

Competing interests

All the authors are currently employed by Janssen Research and Development, as full-time employees or as contractors via Kelly Outsourcing & Consulting Group. There are patent documents related to this work.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–13 and Supplementary Tables 1–3. (PDF 2267 kb)

Life Sciences Reporting Summary (PDF 193 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mullican, S., Lin-Schmidt, X., Chin, CN. et al. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates. Nat Med 23, 1150–1157 (2017).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research